Moderna Recognized as Top Employer for Eleventh Year in a Row

Moderna, Inc., a leader in mRNA technology, has been named a top employer in the biopharmaceutical industry by Science's 2025 Top Employers Survey. This marks the eleventh consecutive year Moderna has received this accolade, highlighting its dedication to innovation and employee-oriented culture. CEO Stéphane Bancel expressed pride in the recognition, citing the company's focus on advancing its mRNA medicine pipeline and employee career development.

In 2025, Moderna's third product, mNEXSPIKE®, a COVID-19 vaccine, gained approval for adults 65 and older, and those aged 12-64 with risk factors. The company continues to expand its manufacturing hubs in Australia, Canada, and the UK to enhance pandemic response capabilities. These efforts underline Moderna's commitment to social responsibility and public health.

Tracey Franklin, Chief People and Digital Technology Officer, emphasized the role of technology, including AI and robotics, in fostering innovation within the company. Science's survey results, drawn from over 5,500 participants mainly in North America, Europe, and Asia, underscore Moderna’s reputation as a leading employer in the biotech sector.